Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 2Spinal Cord Neoplasms 1Sarcoma, Kaposi 1Optic Nerve Glioma 1Oligodendroglioma 1Neurofibromatosis 2 1Neurofibromatoses 1Neoplasms by Histologic Type 1Meningioma 1Medulloblastoma 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid 1HIV Infections 1Familial ependymoma 1Central Nervous System Neoplasms 1Breast Neoplasms 1Astrocytoma 1AIDS-related Kaposi sarcoma 1

Interventions

Temozolomide 10Radiotherapy 5Carboplatin 5Vincristine 4Radiosurgery 4Surveys and Questionnaires 3Magnetic Resonance Imaging 3Etoposide 3Bevacizumab 3etoposide phosphate 2Vorinostat 2Magnetic Resonance Spectroscopy 2Lomustine 2Irinotecan 2Immunoglobulin G 2Ifosfamide 2Fluorodeoxyglucose F18 2Disulfides 2Cisplatin 2veliparib 1tozuleristide 1romidepsin 1perillyl alcohol 1pembrolizumab 1olutasidenib 1lonafarnib 1ispinesib 1emvododstat 1cediranib 1abemaciclib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Spinal Cord Neoplasms × emvododstat × Clear all
NCT01158300 2015-05-04

PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors

Pediatric Brain Tumor Consortium

Phase 1 Completed
28 enrolled
CNS

Familial ependymoma, Astrocytoma, Medulloblastoma, Meningioma, Oligodendroglioma, Spinal Cord Neoplasms, Central Nervous System Neoplasms, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡